Eagle Point Credit: Q4 Earnings Indicate Both Strength And Weakness (Rating Downgrade)
Eagle Point Credit offers a 21.5% dividend yield but faces capital loss and NAV decline. Learn why ECC stock is downgraded to ...
The Healthy on MSN1 天
“Why Is My Immune System So Weak?” Expert Doctors Share 8 Major Causes
If you're catching colds or feeling under the weather more often during this season, a few straightforward changes to your ...
Cure Today3 天
UGN-102 Shows Complete Response Rates in Low-Grade Bladder Cancer
Among patients with low-grade, intermediate-risk NMIBC, UGN-102 generated robust, durable responses in an analysis of the ...
UroToday3 天
ASCO GU 2025: Overcoming Challenges of Antibody Drug Conjugate Toxicity in Bladder Cancer
Based on work Dr. Petrylak presented at ASCO 2024 looking at dose adjustment and efficacy of enfortumab vedotin, most ...
Cochrane3 天
Does treatment with GLP-1 receptor agonists prevent complications for people with chronic ...
• Glucagon-like peptide 1 receptor agonists (GLP-1) (medicines used to lower blood glucose) probably reduce the risk of death due to any cause but may have little or no death due to a heart attack in ...
Cure Today4 天
GAP Regimen May Not Improve Survival in Biliary Tract Cancer Subset
The addition of nab-paclitaxel to gemcitabine and cisplatin did not improve survival in advanced biliary tract cancer.
Targeted Oncology6 天
UGN-102 Shows Lasting Responses in Low-Grade, Intermediate-Risk NMIBC
UGN-102 led to durable responses in low-grade, intermediate-risk bladder cancer, per phase 3 study findings at the 2025 ...